
欧洲测序试剂市场预测至 2028 年 - COVID-19 影响和区域分析(按技术(下一代测序、桑格测序和第三代测序)、应用(农业基因组学和法医学、临床调查、肿瘤学、生殖健康和其他应用),试剂类型(对照试剂盒、文库试剂盒、模板试剂盒、测序试剂盒和其他试剂类型)和最终用户(医院和诊所、研究机构、制药和生物技术公司和其他最终用户)
No. of Pages: 165 | Report Code: TIPRE00022818 | Category: Life Sciences
No. of Pages: 165 | Report Code: TIPRE00022818 | Category: Life Sciences
测序过程中会用到测序试剂。这些试剂的使用很大程度上取决于要获得的所需结果。它们构成了测序反应的重要组成部分,也可用于各种其他应用。
测序过程中会使用测序试剂。这些试剂的使用很大程度上取决于要获得的所需结果。它们构成了测序反应的重要组成部分,也可用于各种其他应用。基因组测序的成本急剧下降,在过去六七年里下降了近一百万倍。近年来,二代测序价格大幅下降。许多测试服务的成本为数百美元,降低的成本和更高的速度不仅可以给他们带来更大的利润空间,而且能够更快地处理,并可能带来更高的消费者负载。成本的迅速降低现在有助于临床研究,但更快的速度和更低的价格点可能会吸引健康初创企业来帮助消费者。因此,Illumina 和 Roche 等主要市场参与者推出了突破性技术,降低了测序成本并缩短了时间。由于基因组学领域的进步、不同测序方法和策略的发展等因素,测序成本显着下降。此外,根据国际糖尿病联盟 (IDF) 的数据,在预测期内,全球人群的糖尿病患病率可能会增加约 35%。随着慢性病发病率的加快,危及生命疾病的基因组学研究在过去五年中取得了迅速进展,推动了市场的增长。
欧洲COVID-19确诊病例的快速增长对欧洲经济产生了重大影响。基因组测序日益成为研究疾病爆发的重要工具。许多国家已开始报告患者样本中冠状病毒的基因组序列。自COVID-19大流行以来,对测序试剂盒的需求一直很高,因此许多公司正在增加试剂盒的产量。最近几天,欧洲的实验室增强了基因组测序能力。该地区的国家更喜欢内部分析而不是外包工作。许多私人和政府组织正在为基于测序的研究筹集资金。因此,COVID-19的爆发正在推动欧洲测序试剂市场的增长。
欧洲测序试剂市场按技术分为二代测序、桑格测序和三代测序。下一代测序细分市场在 2020 年占据最大市场份额。然而,预计桑格测序细分市场在预测期内的复合年增长率最高。
欧洲测序试剂市场按试剂类型分为对照试剂盒、文库试剂盒、模板试剂盒、测序试剂盒和其他试剂类型。测序试剂盒细分市场在 2020 年占据最大市场份额,而文库试剂盒细分市场预计在预测期内将实现最高的复合年增长率。
欧洲测序试剂市场按应用分为农业基因组学和法医学、临床研究、肿瘤学、生殖健康和其他应用。肿瘤学领域在 2020 年占据最大的市场份额。然而,预计临床研究领域在预测期内的市场复合年增长率最高。
基于最终用户方面,欧洲测序试剂市场分为医院和诊所、研究机构、制药和生物技术公司以及其他最终用户。研究机构细分市场在 2020 年占据了最大的市场份额。此外,预计该细分市场在预测期内的复合年增长率最高。
一些准备欧洲测序试剂市场报告时提到的主要和次要来源是英国国家医疗服务体系(NHS)、世界卫生组织(WHO)和德国生物技术工业协会(DIB)。
Strategic insights for Europe Sequencing Reagents involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,819.68 Million |
Market Size by 2028 | US$ 4,021.33 Million |
Global CAGR (2021 - 2028) | 12.0% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 技术
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Sequencing Reagents refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Sequencing Reagents Market is valued at US$ 1,819.68 Million in 2021, it is projected to reach US$ 4,021.33 Million by 2028.
As per our report Europe Sequencing Reagents Market, the market size is valued at US$ 1,819.68 Million in 2021, projecting it to reach US$ 4,021.33 Million by 2028. This translates to a CAGR of approximately 12.0% during the forecast period.
The Europe Sequencing Reagents Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Sequencing Reagents Market report:
The Europe Sequencing Reagents Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Sequencing Reagents Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Sequencing Reagents Market value chain can benefit from the information contained in a comprehensive market report.